Zobrazeno 1 - 10
of 183
pro vyhledávání: '"Yuichiro Takeda"'
Autor:
Yuichiro Takeda, Go Naka, Yuki Katsuya, Konomi Kobayashi, Manabu Suzuki, Masao Hashimoto, Satoshi Hirano, Yukari Uemura
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-15 (2023)
Abstract Background Pemetrexed is an efficacious multi-targeted antifolate with acceptable toxicity for non-squamous non-small cell lung cancer (non-Sq NSCLC) and malignant pleural mesothelioma. Vitamin B12 and folic acid as premedication can reduce
Externí odkaz:
https://doaj.org/article/b54f1d9523c74b46a6c00a96f32e8867
Autor:
Manabu Suzuki, Shota Fujimoto, Keita Sakamoto, Kentaro Tamura, Satoru Ishii, Motoyasu Iikura, Shinyu Izumi, Yuichiro Takeda, Masayuki Hojo, Haruhito Sugiyama
Publikováno v:
The Clinical Respiratory Journal, Vol 17, Iss 2, Pp 96-104 (2023)
Abstract Introduction This study aimed to evaluate the correlation and agreement between end‐tidal CO2 (EtCO2) measured with the novel portable capnometer (CapnoEye®) and partial pressure of arterial carbon dioxide (PaCO2) levels in patients with
Externí odkaz:
https://doaj.org/article/d19e082969e842e69234c353c423546c
Autor:
Yuichiro Takeda, Yusaku Kusaba, Yoko Tsukita, Yukari Uemura, Eisaku Miyauchi, Takaya Yamamoto, Hiroshi Mayahara, Akito Hata, Hidetsugu Nakayama, Satoshi Tanaka, Junji Uchida, Kazuhiro Usui, Tatsuya Toyoda, Motohiro Tamiya, Masahiro Morimoto, Yuko Oya, Takeshi Kodaira, Keiichi Jingu, Hisatoshi Sugiura
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 37, Iss , Pp 57-63 (2022)
Purpose: Intensity-modulated radiotherapy (IMRT) is currently used more commonly than 3-dimensional conformal radiation for definitive thoracic radiation. We examined the efficacy profiles of concurrent chemoradiotherapy (CCRT) with IMRT after durval
Externí odkaz:
https://doaj.org/article/50d03165c0224d01824af0e40ec388da
Autor:
Manabu Suzuki, MD, Hiromu Watanabe, MD, Masao Hashimoto, MD, Satoru Ishii, MD, Go Naka, MD, Motoyasu Iikura, MD, Shinyu Izumi, MD, Yuichiro Takeda, MD, Masayuki Hojo, MD, Haruhito Sugiyama, MD
Publikováno v:
Radiology Case Reports, Vol 17, Iss 11, Pp 4232-4238 (2022)
Pulmonary hamartomas are common benign lung tumors; however, endobronchial hamartomas are relatively rare. We report a case of asymptomatic endobronchial hamartoma in a 51-year-old man. Chest computed tomography revealed a 10-mm protrusion in the rig
Externí odkaz:
https://doaj.org/article/ad1aa2d2e1434f4e8ec668a535978aad
Autor:
Momoko Morishita, Manabu Suzuki, Hiromu Watanabe, Chie Morita, Akane Ishida, Masao Hashimoto, Go Naka, Yuichiro Takeda, Masayuki Hojo, Haruhito Sugiyama
Publikováno v:
Thoracic Cancer, Vol 12, Iss 10, Pp 1613-1616 (2021)
Abstract A 62‐year‐old woman with rheumatoid arthritis and a history of receiving immunosuppressant therapy had a recurrence of lung adenocarcinoma with EGFR L858R mutation. Following 14 months of treatment with erlotinib, computed tomography (CT
Externí odkaz:
https://doaj.org/article/0b1417f52d8a4b5aa0f17f5e18adaf94
Autor:
Yuichiro Takeda, Go Naka, Yoh Yamaguchi, Masao Hashimoto, Manabu Suzuki, Shinyu Izumi, Haruhito Sugiyama
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Osimertinib, a third-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI), can be used as second-line treatment for lung cancer patients harboring the T790M substitution. Although osimertinib is more
Externí odkaz:
https://doaj.org/article/f8dbd7f2dce347dd84206d01c7f380d8
Autor:
Yuriko Ueki, Manabu Suzuki, Yuriko Horikawa, Hiromu Watanabe, Yoh Yamaguchi, Chie Morita, Akinari Tsukada, Hiroshi Takumida, Yusaku Kusaba, Takashi Katsuno, Yoshie Tsujimoto, Keita Sakamoto, Masao Hashimoto, Junko Terada, Satoru Ishii, Jin Takasaki, Go Naka, Motoyasu Iikura, Shinyu Izumi, Yuichiro Takeda, Masayuki Hojo, Haruhito Sugiyama
Publikováno v:
Thoracic Cancer, Vol 11, Iss 9, Pp 2731-2735 (2020)
Abstract Immune checkpoint inhibitors (ICIs) are reportedly effective against many kinds of neoplasm, but may be responsible for several kinds of immune‐related adverse events (irAEs). Among these irAEs, the incidence of myelosuppression due to ICI
Externí odkaz:
https://doaj.org/article/25dedb817d3148c69a374d619a8d248d
Autor:
Ryogo Minamimoto, Yuichiro Takeda, Masatoshi Hotta, Jun Toyohara, Kazuhiko Nakajima, Go Naka, Haruhito Sugiyama
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-10 (2019)
Abstract Background 4′-[Methyl-11C] thiothymidine (4DST) PET/CT provides DNA synthesis imaging, which represented a higher correlation with the proliferation in advanced non-small cell lung cancer (NSCLC) than that from imaging with FDG. The aim of
Externí odkaz:
https://doaj.org/article/3ea90fa8af76425ba801d091ad6e9213
Autor:
Nobukazu Fujimoto, MD, PhD, Morihito Okada, MD, PhD, Takashi Kijima, MD, PhD, Keisuke Aoe, MD, PhD, Terufumi Kato, MD, Kazuhiko Nakagawa, MD, PhD, Yuichiro Takeda, MD, PhD, Toyoaki Hida, MD, PhD, Kuninobu Kanai, MD, PhD, Jun Hirano, MPharm, Yuichiro Ohe, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 3, Pp 100135- (2021)
Introduction: We examined the long-term efficacy and safety of nivolumab, a human monoclonal antibody that inhibits interactions between the programmed cell death protein-1 receptor and its ligands (programmed death-ligand 1 and programmed death-liga
Externí odkaz:
https://doaj.org/article/6daaa024a9364fefa2c9b2eb6842a85c
Publikováno v:
Respirology Case Reports, Vol 8, Iss 2, Pp n/a-n/a (2020)
Lung cancer immunotherapy is an effective treatment option; however, it can be hampered by adverse events, including pancreatitis, associated with excessive immune activation. Here, we report the case of a 70‐year‐old patient who presented with r
Externí odkaz:
https://doaj.org/article/cb45b2f15cc84bf2884599566c6c00e1